Show simple item record

dc.contributor.authorMartínez Sellés, Manueles_ES
dc.contributor.authorBouza, Emilioes_ES
dc.contributor.authorDíez Villanueva, Pabloes_ES
dc.contributor.authorValerio, Maricelaes_ES
dc.contributor.authorFariñas Álvarez, María del Carmen es_ES
dc.contributor.authorMuñoz García, Antonio J.es_ES
dc.contributor.authorRuiz Morales, Josefaes_ES
dc.contributor.authorGálvez Acebal, Juanes_ES
dc.contributor.authorAntorrena, Isabeles_ES
dc.contributor.authorHera Galarza, Jesús María de laes_ES
dc.contributor.authorNavas, Enriquees_ES
dc.contributor.authorMuñoz, Patriciaes_ES
dc.contributor.authorGAMES study groupes_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2017-08-07T11:25:48Z
dc.date.available2017-08-07T11:25:48Z
dc.date.issued2016es_ES
dc.identifier.issn1774-024Xes_ES
dc.identifier.issn1969-6213es_ES
dc.identifier.urihttp://hdl.handle.net/10902/11527
dc.description.abstractAims: To describe the characteristics of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI). Methods and results: This study was performed using the GAMES database, a national prospective registry of consecutive patients with IE in 26 Spanish hospitals. Of the 739 cases of IE diagnosed during the study, 1.3% were post-TAVI IE, and these 10 cases, contributed by five centres, represented 1.1% of the 952 TAVIs performed. Mean age was 80 years. All valves were implanted transfemorally. IE appeared a median of 139 days after implantation. The mean age-adjusted Charlson comorbidity index was 5.45. Chronic kidney disease was frequent (five patients), as were atrial fibrillation (five patients), chronic obstructive pulmonary disease (four patients), and ischaemic heart disease (four patients). Six patients presented aortic valve involvement, and four only mitral valve involvement; the latter group had a higher percentage of prosthetic mitral valves (0% vs. 50%). Vegetations were found in seven cases, and four presented embolism. One patient underwent surgery. Five patients died during follow-up: two of these patients died during the admission in which the valve was implanted. Conclusions: IE is a rare but severe complication after TAVI which affects about 1% of patients and entails a relatively high mortality rate. IE occurred during the first year in nine of the 10 patients.es_ES
dc.format.extent8 p.es_ES
dc.language.isoenges_ES
dc.publisherEuropa Digital & Publishinges_ES
dc.rights© Europa Digital & Publishing. "Reprinted from EuroIntervention Vol 11 number 10, Manuel Martínez-Sellés; Emilio Bouza; Pablo Díez-Villanueva et al., Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation, Pages 1180-7, Copyright 2016, with permission from Europa Digital & Publishing." The published paper from which material is reproduced must also be cited in the corresponding reference list.es_ES
dc.sourceEuroIntervention 2016;11:1180-1187es_ES
dc.titleIncidence and clinical impact of infective endocarditis after transcatheter aortic valve implantationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.DOI10.4244/EIJY15M02_05es_ES
dc.type.versionpublishedVersiones_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record